| Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer S Suman, PK Sharma, G Rai, S Mishra, D Arora, P Gupta, Y Shukla Biochemical and biophysical research communications 472 (3), 401-409, 2016 | 71 | 2016 |
| Emerging role of extracellular vesicles in immune regulation and cancer progression S Mittal, P Gupta, P Chaluvally-Raghavan, S Pradeep Cancers 12 (12), 3563, 2020 | 58 | 2020 |
| B cells as an immune-regulatory signature in ovarian cancer P Gupta, C Chen, P Chaluvally-Raghavan, S Pradeep Cancers 11 (7), 894, 2019 | 50 | 2019 |
| RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site J George, Y Li, IP Kadamberi, D Parashar, SW Tsaih, P Gupta, ... Cell reports 37 (5), 2021 | 47 | 2021 |
| Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer S Suman, T Basak, P Gupta, S Mishra, V Kumar, S Sengupta, Y Shukla Journal of proteomics 148, 183-193, 2016 | 41 | 2016 |
| Oncostatin M receptor–targeted antibodies suppress STAT3 signaling and inhibit ovarian cancer growth A Geethadevi, A Nair, D Parashar, Z Ku, W Xiong, H Deng, Y Li, J George, ... Cancer research 81 (20), 5336-5352, 2021 | 38 | 2021 |
| ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis C Chen, P Gupta, D Parashar, GG Nair, J George, A Geethadevi, W Wang, ... Oncogene 39 (14), 2921-2933, 2020 | 38 | 2020 |
| Tumor derived extracellular vesicles drive T cell exhaustion in tumor microenvironment through sphingosine mediated signaling and impacting immunotherapy outcomes in ovarian cancer P Gupta, IP Kadamberi, S Mittal, SW Tsaih, J George, S Kumar, ... Advanced Science 9 (14), 2104452, 2022 | 35 | 2022 |
| Patient-derived ovarian cancer spheroids rely on PI3K-AKT signaling addiction for cancer stemness and chemoresistance D Parashar, A Geethadevi, S Mittal, LA McAlarnen, J George, ... Cancers 14 (4), 958, 2022 | 19 | 2022 |
| Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients P Gupta, S Suman, M Mishra, S Mishra, N Srivastava, V Kumar, PK Singh, ... PROTEOMICS–Clinical Applications 10 (5), 564-573, 2016 | 16 | 2016 |
| Metabolic reprogramming in tumor-associated macrophages in the ovarian tumor microenvironment S Kumar, S Mittal, P Gupta, M Singh, P Chaluvally-Raghavan, S Pradeep Cancers 14 (21), 5224, 2022 | 10 | 2022 |
| Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies LA McAlarnen, P Gupta, R Singh, S Pradeep, P Chaluvally-Raghavan Molecular Therapy-Oncolytics 26, 347-359, 2022 | 5 | 2022 |
| Establishment of in vivo ovarian cancer mouse models using intraperitoneal tumor cell injection S Mittal, P Gupta, P Chaluvally-Raghavan, S Pradeep Ovarian Cancer: Methods and Protocols, 247-254, 2022 | 4 | 2022 |
| Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model S Mittal, S Kumar, P Gupta, M Singh, P Chaluvally-Raghavan, S Pradeep STAR protocols 5 (2), 102943, 2024 | | 2024 |
| Breast Cancer: Current Trends in Molecular Research SP Authors Akanksha Nigam Shankar Suman | | 2022 |
